Study of BBIL's ROTAVAC® and ROTAVAC 5CM Vaccines in Zambia
Clinical trial NCT03602053 · COMPLETED
Trial details
- NCT number
- NCT03602053
- Sponsor
- Centre for Infectious Disease Research in Zambia
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-22
- Primary completion
- 2019-10-04
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.